Sanofi-Aventis (France) Expands Drug R&D Activities in China

LONDON (Reuters) - France's Sanofi-Aventis said on Tuesday it was expanding its research and development in presence in China, underlying a growing trend by global drug companies seeking to tap into the country's science base.
MORE ON THIS TOPIC